• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Biological screening of natural products and drug innovation in China.中国天然产物的生物筛选与药物创新
Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):1093-105. doi: 10.1098/rstb.2007.2036.
2
Natural products as starting points for future anti-malarial therapies: going back to our roots?天然产物作为未来抗疟疗法的起点:回归本源?
Malar J. 2011 Mar 15;10 Suppl 1(Suppl 1):S3. doi: 10.1186/1475-2875-10-S1-S3.
3
The strategies and techniques of drug discovery from natural products.天然产物药物发现的策略与技术。
Pharmacol Ther. 2020 Dec;216:107686. doi: 10.1016/j.pharmthera.2020.107686. Epub 2020 Sep 19.
4
Japan-China Joint Medical Workshop on Drug Discoveries and Therapeutics 2008: The need of Asian pharmaceutical researchers' cooperation.2008年日中药物研发与治疗联合医学研讨会:亚洲制药研究人员合作的必要性。
Drug Discov Ther. 2008 Oct;2(5):262-3.
5
Natural products as leads to anticancer drugs.作为抗癌药物先导物的天然产物。
Clin Transl Oncol. 2007 Dec;9(12):767-76. doi: 10.1007/s12094-007-0138-9.
6
Natural products for the treatment of stress-induced depression: Pharmacology, mechanism and traditional use.天然产物治疗应激诱导的抑郁症:药理学、机制和传统用途。
J Ethnopharmacol. 2022 Mar 1;285:114692. doi: 10.1016/j.jep.2021.114692. Epub 2021 Nov 3.
7
Fastidious Anatomization of Biota Procured Compounds on Cancer Drug Discovery.对癌症药物发现中获得的生物化合物进行精细剖析。
Curr Pharm Biotechnol. 2020;21(5):354-363. doi: 10.2174/1389201020666191128145015.
8
Virtual screening on natural products for discovering active compounds and target information.基于天然产物的虚拟筛选以发现活性化合物和靶点信息。
Curr Med Chem. 2003 Nov;10(21):2327-42. doi: 10.2174/0929867033456729.
9
Traditional Chinese medicine--sea urchin.传统中药——海胆。
Mini Rev Med Chem. 2014;14(6):537-42. doi: 10.2174/1389557514666140529224147.
10
High-throughput screening for bioactive components from traditional Chinese medicine.中药生物活性成分的高通量筛选
Comb Chem High Throughput Screen. 2010 Dec;13(10):837-48. doi: 10.2174/138620710793360257.

引用本文的文献

1
Antioxidant and Anticancer Activities of L. f. From Siriya Kalvarayan Hills.来自西里亚卡尔瓦拉扬山的L. f. 的抗氧化和抗癌活性。
Scientifica (Cairo). 2025 May 28;2025:8055358. doi: 10.1155/sci5/8055358. eCollection 2025.
2
Efficient Biosynthesis of Gastrodin by UDP-Glycosyltransferase from .来自……的UDP-糖基转移酶高效生物合成天麻素
J Microbiol Biotechnol. 2025 Mar 26;35:e2501002. doi: 10.4014/jmb.2501.01002.
3
Recombinant Expression and Characterization of an Alkali-tolerant UDP-Glycosyltransferase from and Its Biosynthesis of Gastrodin.来自[具体来源未给出]的一种耐碱UDP-糖基转移酶的重组表达、特性分析及其天麻素的生物合成
J Microbiol Biotechnol. 2024 Nov 22;35:e2410029. doi: 10.4014/jmb.2410.10029.
4
Computational screening and molecular docking of compounds from Traditional Chinese Medicine (TCM) by targeting DNA topoisomerase I to design potential anticancer drugs.基于 DNA 拓扑异构酶 I 的靶点,运用计算筛选和中药(TCM)化合物的分子对接,设计潜在的抗癌药物。
PLoS One. 2024 Sep 12;19(9):e0310364. doi: 10.1371/journal.pone.0310364. eCollection 2024.
5
Screening of herbal extracts binding with vascular endothelial growth factor by applying HerboChip platform.应用草药芯片平台筛选与血管内皮生长因子结合的草药提取物。
Chin Med. 2024 Sep 9;19(1):122. doi: 10.1186/s13020-024-00987-x.
6
Glycyrol Prevents the Progression of Psoriasis-like Skin Inflammation via Immunosuppressive and Anti-Inflammatory Actions.甘草次酸通过免疫抑制和抗炎作用预防银屑病样皮肤炎症的进展。
Int J Mol Sci. 2023 Dec 11;24(24):17335. doi: 10.3390/ijms242417335.
7
Machine Learning-Assisted Screening of Herbal Medicine Extracts as Vaccine Adjuvants.机器学习辅助筛选草药提取物作为疫苗佐剂。
Front Immunol. 2022 May 19;13:847616. doi: 10.3389/fimmu.2022.847616. eCollection 2022.
8
Therapeutic application of Carica papaya leaf extract in the management of human diseases.木瓜叶提取物在人类疾病治疗中的应用。
Daru. 2020 Dec;28(2):735-744. doi: 10.1007/s40199-020-00348-7. Epub 2020 May 5.
9
Enhancement Effect of Shark Cartilage Extract on Treatment of with Artemisinin and Glucantime and Evaluation of killing Factors and Apoptosis Condition.鲨鱼软骨提取物对青蒿素和戊烷脒治疗的增强作用以及杀伤因子和凋亡情况的评估
Iran J Pharm Res. 2019 Spring;18(2):887-902. doi: 10.22037/ijpr.2019.1100656.
10
YaTCM: Yet another Traditional Chinese Medicine Database for Drug Discovery.YaTCM:另一个用于药物发现的中医数据库。
Comput Struct Biotechnol J. 2018 Nov 23;16:600-610. doi: 10.1016/j.csbj.2018.11.002. eCollection 2018.

本文引用的文献

1
Retinoic acid and arsenic for treating acute promyelocytic leukemia.维甲酸与砷剂治疗急性早幼粒细胞白血病
PLoS Med. 2005 Jan;2(1):e12. doi: 10.1371/journal.pmed.0020012.
2
Multicomponent therapeutics for networked systems.用于网络系统的多组分疗法。
Nat Rev Drug Discov. 2005 Jan;4(1):71-8. doi: 10.1038/nrd1609.
3
Toxicity of novel anti-hepatitis drug bicyclol: a preclinical study.新型抗肝炎药物双环醇的毒性:一项临床前研究。
World J Gastroenterol. 2005 Feb 7;11(5):665-71. doi: 10.3748/wjg.v11.i5.665.
4
Effects of artemisinin-tagged holotransferrin on cancer cells.青蒿素标记的全转铁蛋白对癌细胞的影响。
Life Sci. 2005 Jan 28;76(11):1267-79. doi: 10.1016/j.lfs.2004.08.020. Epub 2004 Nov 23.
5
DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells.新型拓扑异构酶II抑制剂沙尔威辛诱导人乳腺癌MCF-7细胞的DNA损伤、c-myc抑制及细胞凋亡
Cancer Chemother Pharmacol. 2005 Mar;55(3):286-94. doi: 10.1007/s00280-004-0877-z. Epub 2004 Nov 16.
6
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.黄连素是一种新型降胆固醇药物,其作用机制独特,与他汀类药物不同。
Nat Med. 2004 Dec;10(12):1344-51. doi: 10.1038/nm1135. Epub 2004 Nov 7.
7
Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.端粒酶抑制是三尖杉碱处理的人肺腺癌A549细胞中的一个特定早期事件。
Biochem Biophys Res Commun. 2004 Oct 15;323(2):660-7. doi: 10.1016/j.bbrc.2004.08.135.
8
Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine.靛玉红及其衍生物的分子机制:源自传统中药的新型抗癌分子。
J Cancer Res Clin Oncol. 2004 Nov;130(11):627-35. doi: 10.1007/s00432-004-0579-2. Epub 2004 Aug 31.
9
Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol.双环醇对刀豆蛋白A诱导的小鼠肝损伤中Fas/FasL mRNA表达及TNF-α释放的抑制作用
World J Gastroenterol. 2004 Jun 15;10(12):1775-9. doi: 10.3748/wjg.v10.i12.1775.
10
Identification of phase I and phase II metabolites of Guanfu base A hydrochloride in human urine.
Eur J Drug Metab Pharmacokinet. 2003 Oct-Dec;28(4):265-72. doi: 10.1007/BF03220178.

中国天然产物的生物筛选与药物创新

Biological screening of natural products and drug innovation in China.

作者信息

Wang Ming-Wei, Hao Xiaojiang, Chen Kaixian

机构信息

The National Centre for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People's Republic of China.

出版信息

Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):1093-105. doi: 10.1098/rstb.2007.2036.

DOI:10.1098/rstb.2007.2036
PMID:17317643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2435573/
Abstract

Natural products have been applied to human healthcare for thousands of years. Drug discovery in ancient times was largely by chance and based on clinical practices. As understanding of therapeutic benefits deepens and demands for natural products increase, previously serendipitous discoveries evolve into active searches for new medicines. Many drugs presently prescribed by physicians are either directly isolated from plants or are artificially modified versions of natural products. Scientists are looking for lead compounds with specific structures and pharmacological effects often from natural sources. Experiences and successes of Chinese scientists in this specialized area have resulted in a number of widely used drugs. The tremendous progress made in life sciences has not only revealed many pathological processes of diseases, but also led to the establishment of various molecular and cellular bioassays in conjunction with high-throughput technologies. This is advantageous and permits certain natural compounds that are difficult to isolate and purify, and compounds that are difficult to synthesize, to be assayed. The transition from traditional to empirical and to molecular screening will certainly increase the probability of discovering new leads and drug candidates from natural products.

摘要

天然产物应用于人类医疗保健已有数千年历史。古代的药物发现很大程度上是偶然的,且基于临床实践。随着对治疗益处的理解不断深入以及对天然产物的需求增加,以前偶然的发现逐渐演变为对新药的积极探索。目前医生开具的许多药物要么直接从植物中分离出来,要么是天然产物的人工改性版本。科学家们常常从天然来源寻找具有特定结构和药理作用的先导化合物。中国科学家在这一专业领域的经验和成功促成了许多广泛使用的药物。生命科学取得的巨大进展不仅揭示了许多疾病的病理过程,还导致了结合高通量技术建立各种分子和细胞生物测定法。这具有优势,使得某些难以分离和纯化的天然化合物以及难以合成的化合物能够得到测定。从传统筛选到经验性筛选再到分子筛选的转变肯定会增加从天然产物中发现新先导化合物和候选药物的可能性。